Nitric oxide's role in heart failure: pathophysiology and treatment. Introduction.
Cohn
Jay N
JN
Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Loscalzo
Joseph
J
Franciosa
Joseph A
JA
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001741:Black or African American; D000804:Angiotensin II / Q000378:metabolism; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000208:ethnology / Q000503:physiopathology*; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism*; D020257:Ventricular Remodeling / Q000187:drug effects / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II; D009569:Nitric Oxide